Patents by Inventor Klaus Peter Schafer

Klaus Peter Schafer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7202055
    Abstract: Described is a novel process for the production of at least one protein of interest by secretion of the protein of interest from a pro- or eukaryotic host cell in a compartment system, which host cell is stably expressing a secretion system and capable of heterologous secretion of the protein of interest and which compartment system has at least a first and a second compartment and wherein the host cell is located in the first compartment and wherein the first and second compartment are separated from each other by a barrier, wherein the barrier is permeable for the secreted protein of interest, but not permeable for the host cell.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: April 10, 2007
    Assignee: Altana Pharma AG
    Inventors: Klaus Peter Schäfer, Ingeborg Mühldorfer
  • Publication number: 20040023329
    Abstract: Described is a novel process for the production of at least one protein of interest by secretion of the protein of interest from a pro- or eukaryotic host cell in a compartment system, which host cell is stably expressing a secretion system and capable of heterologous secretion of the protein of interest and which compartment system has at least a first and a second compartment and wherein the host cell is located in the first compartment and wherein the first and second compartment are separated from each other by a barrier, wherein the barrier is permeable for the secreted protein of interest, but not permeable for the host cell.
    Type: Application
    Filed: July 25, 2003
    Publication date: February 5, 2004
    Inventors: Klaus Peter Schafer, Ingeborg Muhldorfer
  • Patent number: 5874406
    Abstract: Polypeptide analogs of human the human lung surfactant protein, SP-C, are provided. The polypeptides have the following structure: ##STR1## wherein A is H or Phe, B is Phe or Trp, and C is Ile, Leu, or Ser. They exhibit surfactant activity and are useful in the treatment of respiratory distress syndromes in premature infants and adults.
    Type: Grant
    Filed: November 27, 1996
    Date of Patent: February 23, 1999
    Assignee: BYK Gulden Lomberg Chemische Fabrik GmbH
    Inventors: Klaus Peter Schafer, Klaus Melchers